MILAN (Reuters) -European drugmakers stocks fell in early trading on Monday after U.S. President Donald Trump said he would sign an executive order on reducing prescription drug and pharmaceutical prices.
Frankfurt-listed shares in Novo Nordisk, AstraZeneca, GSK and Roche Holding were down between 1% and 5%, underperforming a gain in broader European stock index futures.
Their declines followed losses in shares of Asian competitors.
In Japan, the pharmaceutical sector fell over 4% to become the worst performer among the Tokyo Stock Exchange’s 33 industry sub-indexes. Indian pharma stocks were also lower.
(Reporting by Danilo Masoni; Editing by Amanda Cooper)
